3+ 4/2002 - Společnost pro pojivové tkáně

– Lequesne M., (1994) Symptomatic clow-acting
drugs in osteoarthritis: A novel therapeutic, concept?
Rev Rhum (Engl/Ed) 61:69–73
– Lequesne M. G., Mery C., Samson M. et al.,
(1987) Indexes of severity for osteoarthritis of the
hip and knee,Scand J Rheumatology (Suppl 65) 85-89
– Morreale P.,Manopulo R.,Gelati M. et al. (1996)
Comparison of the antiinflammatory efficacy of
chondroitin sulfate and diclofenac sodium in
patients with knee osteoarthritis, J Rheumatol,
23:1385-1391
– Moskowitz R. L. (2000) Role of collagen
hydrolysate in bone and joint disease, Arthritis
Rheum 30:87-99.
– Novotná J., Adam M., (1986) Anticollagen antibodies
in patients with osteoarthrosis, Conn. Tiss.
Dis. 5:3-11.
– Oesser S., Adam M., Babel W. et al, (1999),
Administration of 14C labeled gelatin hydrolysate
leads to an accummulation of radioactivity in cartilage
of mice(C57/BL), J Nutr 120:1891-1895.
– Špaček P., Hulejová H., Adam M. (1997) Ion
exchange HPLC determination of pyridinoline cross
links in urine as markers of bone resorption, Liq
Chrom & Rel Technol 20:1921-1930
– Van de Loo FAJ, Joosten LAB, van Lent PLEM, et
al. (1995) Role of interleukin-1, tumor necrosis factor
á, and interleukin-6 in cartilage proteoglycan
metabolismus and destruction: effect of in situ
blocking in murine antigen- and zymosan-induced
arthritis. Arthritis Rheum. 38:164-72:
– Van Straalen JP, Sanders E, Prummel MF, (1991)
Bone-alkaline phosphatase as indicator of bone formation,
Clin Chim Acta 201:27-34
Author's address: Milan Adam, MD, ScD, Dhc (Reims)
Professor of Medicine and Rheumatology,
Institute of Rheumatology, Na Slupi 4,
CZ 128 50 Prague 2, Czechia
Phone/fax 420-2-2492 1870
e-mail: adam@revma.cz
66
LOCOMOTOR SYSTEM vol. 9, 2002, No. 3+4